China Oncology Precision Medicine Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Oncology Precision Medicine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • bioMerieux SA

    • Myriad Genetics, Inc

    • Quest Diagnostics

    • Illumina, Inc

    • Laboratory Corporation of America Holdings

    • Almac Group Ltd

    • MDx Health, Inc

    • QIAGEN

    • ANGLE plc

    • GlaxoSmithKline plc

    • Pacific Biosciences of California, Inc

    • Bio-Rad Laboratories, Inc

    • Novartis AG

    • Asuragen, Inc

    • BGI Group

    • Abbott Laboratories

    • F Hoffmann-La Roche AG

    • AstraZeneca PLC

    • Konica Minolta, Inc

    • Bristol Myers Squibb

    • Agilent Technologies, Inc

    • Opko Health,Inc

    By Type:

    • Bladder Cancer

    • Liver Cancer

    • Breast Cancer

    • Lung Cancer

    • Esophagus Cancer

    • Stomach Cancer

    • Cervical Cancer

    • Colorectal Cancer

    • Prostate Cancer

    • Kidney Cancer

    By Application:

    • Diagnostic Centers

    • Hospitals

    • Research & Academic Institutes

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Oncology Precision Medicine Market Overview 2018-2029

    • 1.1 China Oncology Precision Medicine Industry Development Overview

    • 1.2 China Oncology Precision Medicine Industry Development History

    • 1.3 China Oncology Precision Medicine Industry Market Size (2018-2029)

    • 1.4 China Oncology Precision Medicine Market Analysis by Type from Production Side

      • 1.4.1 China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Bladder Cancer (2018-2029)

      • 1.4.2 China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Liver Cancer (2018-2029)

      • 1.4.3 China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Breast Cancer (2018-2029)

      • 1.4.4 China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Lung Cancer (2018-2029)

      • 1.4.5 China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Esophagus Cancer (2018-2029)

      • 1.4.6 China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Stomach Cancer (2018-2029)

      • 1.4.7 China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Cervical Cancer (2018-2029)

      • 1.4.8 China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Colorectal Cancer (2018-2029)

      • 1.4.9 China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Prostate Cancer (2018-2029)

      • 1.4.10 China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Kidney Cancer (2018-2029)

    • 1.5 China Oncology Precision Medicine Market Analysis by Application from Consumption End

      • 1.5.1 China Oncology Precision Medicine Sales Volume, Sales Value and Growth Rate of Diagnostic Centers (2018-2029)

      • 1.5.2 China Oncology Precision Medicine Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.3 China Oncology Precision Medicine Sales Volume, Sales Value and Growth Rate of Research & Academic Institutes (2018-2029)

    • 1.6 China Oncology Precision Medicine Market Analysis by Region

      • 1.6.1 North China Oncology Precision Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Oncology Precision Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Oncology Precision Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Oncology Precision Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Oncology Precision Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Oncology Precision Medicine Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Oncology Precision Medicine Market Size and Growth Rate from 2018-2029

    Chapter 2 China Oncology Precision Medicine Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Oncology Precision Medicine Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Oncology Precision Medicine Market Status and Competition Analysis in 2023

      • 2.2.3 China Oncology Precision Medicine Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Oncology Precision Medicine Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Oncology Precision Medicine Industry Development

    Chapter 3 Oncology Precision MedicineIndustry Chain Analysis

    • 3.1 Oncology Precision Medicine Industry Chain

    • 3.2 Oncology Precision Medicine Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Oncology Precision Medicine Market

    • 3.3 Oncology Precision Medicine Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Oncology Precision Medicine Market

    Chapter 4 China Oncology Precision Medicine Market, by Type

    • 4.1 China Oncology Precision Medicine Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Oncology Precision Medicine Total Production Volume and Growth Rate from Production Side

    • 4.5 China Oncology Precision Medicine Production Volume and Growth Rate, by Type

      • 4.5.1 China Oncology Precision Medicine Production Volume and Growth Rate of Bladder Cancer

      • 4.5.2 China Oncology Precision Medicine Production Volume and Growth Rate of Liver Cancer

      • 4.5.3 China Oncology Precision Medicine Production Volume and Growth Rate of Breast Cancer

      • 4.5.4 China Oncology Precision Medicine Production Volume and Growth Rate of Lung Cancer

      • 4.5.5 China Oncology Precision Medicine Production Volume and Growth Rate of Esophagus Cancer

      • 4.5.6 China Oncology Precision Medicine Production Volume and Growth Rate of Stomach Cancer

      • 4.5.7 China Oncology Precision Medicine Production Volume and Growth Rate of Cervical Cancer

      • 4.5.8 China Oncology Precision Medicine Production Volume and Growth Rate of Colorectal Cancer

      • 4.5.9 China Oncology Precision Medicine Production Volume and Growth Rate of Prostate Cancer

      • 4.5.10 China Oncology Precision Medicine Production Volume and Growth Rate of Kidney Cancer

    Chapter 5 China Oncology Precision Medicine Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Oncology Precision Medicine Total Market Size and Growth Rate from Consumption End

    • 5.5 China Oncology Precision Medicine Market Size and Growth Rate, by Application

      • 5.5.1 China Oncology Precision Medicine Market Size and Growth Rate of Diagnostic Centers

      • 5.5.2 China Oncology Precision Medicine Market Size and Growth Rate of Hospitals

      • 5.5.3 China Oncology Precision Medicine Market Size and Growth Rate of Research & Academic Institutes

    Chapter 6 China Oncology Precision Medicine Market, by Region

    • 6.1 China Oncology Precision Medicine Production Volume and Production Value, by Region

    • 6.2 China Oncology Precision Medicine Sales Volume and Sales Value, by Region

    Chapter 7 North China Oncology Precision Medicine Market Analysis

    • 7.1 North China Oncology Precision Medicine Market, by Type

    • 7.2 North China Oncology Precision Medicine Market, by Application

    Chapter 8 Central China Oncology Precision Medicine Market Analysis

    • 8.1 Central China Oncology Precision Medicine Market, by Type

    • 8.2 Central China Oncology Precision Medicine Market, by Application

    Chapter 9 South China Oncology Precision Medicine Market Analysis

    • 9.1 South China Oncology Precision Medicine Market, by Type

    • 9.2 South China Oncology Precision Medicine Market, by Application

    Chapter 10 East China Oncology Precision Medicine Market Analysis

    • 10.1 East China Oncology Precision Medicine Market, by Type

    • 10.2 East China Oncology Precision Medicine Market, by Application

    Chapter 11 Northeast China Oncology Precision Medicine Market Analysis

    • 11.1 Northeast China Oncology Precision Medicine Market, by Type

    • 11.2 Northeast China Oncology Precision Medicine Market, by Application

    Chapter 12 Southwest China Oncology Precision Medicine Market Analysis

    • 12.1 Southwest China Oncology Precision Medicine Market, by Type

    • 12.2 Southwest China Oncology Precision Medicine Market, by Application

    Chapter 13 Northwest China Oncology Precision Medicine Market Analysis

    • 13.1 Northwest China Oncology Precision Medicine Market, by Type

    • 13.2 Northwest China Oncology Precision Medicine Market, by Application

    Chapter 14 Company Profiles

      • 14.1 bioMerieux SA

        • 14.1.1 bioMerieux SA Company Profile

        • 14.1.2 bioMerieux SA Oncology Precision Medicine Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Myriad Genetics, Inc

        • 14.2.1 Myriad Genetics, Inc Company Profile

        • 14.2.2 Myriad Genetics, Inc Oncology Precision Medicine Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Quest Diagnostics

        • 14.3.1 Quest Diagnostics Company Profile

        • 14.3.2 Quest Diagnostics Oncology Precision Medicine Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Illumina, Inc

        • 14.4.1 Illumina, Inc Company Profile

        • 14.4.2 Illumina, Inc Oncology Precision Medicine Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Laboratory Corporation of America Holdings

        • 14.5.1 Laboratory Corporation of America Holdings Company Profile

        • 14.5.2 Laboratory Corporation of America Holdings Oncology Precision Medicine Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Almac Group Ltd

        • 14.6.1 Almac Group Ltd Company Profile

        • 14.6.2 Almac Group Ltd Oncology Precision Medicine Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 MDx Health, Inc

        • 14.7.1 MDx Health, Inc Company Profile

        • 14.7.2 MDx Health, Inc Oncology Precision Medicine Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 QIAGEN

        • 14.8.1 QIAGEN Company Profile

        • 14.8.2 QIAGEN Oncology Precision Medicine Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 ANGLE plc

        • 14.9.1 ANGLE plc Company Profile

        • 14.9.2 ANGLE plc Oncology Precision Medicine Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 GlaxoSmithKline plc

        • 14.10.1 GlaxoSmithKline plc Company Profile

        • 14.10.2 GlaxoSmithKline plc Oncology Precision Medicine Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Pacific Biosciences of California, Inc

        • 14.11.1 Pacific Biosciences of California, Inc Company Profile

        • 14.11.2 Pacific Biosciences of California, Inc Oncology Precision Medicine Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Bio-Rad Laboratories, Inc

        • 14.12.1 Bio-Rad Laboratories, Inc Company Profile

        • 14.12.2 Bio-Rad Laboratories, Inc Oncology Precision Medicine Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Novartis AG

        • 14.13.1 Novartis AG Company Profile

        • 14.13.2 Novartis AG Oncology Precision Medicine Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Asuragen, Inc

        • 14.14.1 Asuragen, Inc Company Profile

        • 14.14.2 Asuragen, Inc Oncology Precision Medicine Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 BGI Group

        • 14.15.1 BGI Group Company Profile

        • 14.15.2 BGI Group Oncology Precision Medicine Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Abbott Laboratories

        • 14.16.1 Abbott Laboratories Company Profile

        • 14.16.2 Abbott Laboratories Oncology Precision Medicine Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 F Hoffmann-La Roche AG

        • 14.17.1 F Hoffmann-La Roche AG Company Profile

        • 14.17.2 F Hoffmann-La Roche AG Oncology Precision Medicine Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 AstraZeneca PLC

        • 14.18.1 AstraZeneca PLC Company Profile

        • 14.18.2 AstraZeneca PLC Oncology Precision Medicine Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Konica Minolta, Inc

        • 14.19.1 Konica Minolta, Inc Company Profile

        • 14.19.2 Konica Minolta, Inc Oncology Precision Medicine Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Bristol Myers Squibb

        • 14.20.1 Bristol Myers Squibb Company Profile

        • 14.20.2 Bristol Myers Squibb Oncology Precision Medicine Market Performance

        • 14.20.3 Product&Service Introduction

      • 14.21 Agilent Technologies, Inc

        • 14.21.1 Agilent Technologies, Inc Company Profile

        • 14.21.2 Agilent Technologies, Inc Oncology Precision Medicine Market Performance

        • 14.21.3 Product&Service Introduction

      • 14.22 Opko Health,Inc

        • 14.22.1 Opko Health,Inc Company Profile

        • 14.22.2 Opko Health,Inc Oncology Precision Medicine Market Performance

        • 14.22.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Oncology Precision Medicine Industry Research Conclusions

    • 15.2 Oncology Precision Medicine Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Oncology Precision Medicine Industry Market Size (2018-2029)

    • Figure China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Bladder Cancer (2018-2029)

    • Figure China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Liver Cancer (2018-2029)

    • Figure China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Lung Cancer (2018-2029)

    • Figure China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Esophagus Cancer (2018-2029)

    • Figure China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Stomach Cancer (2018-2029)

    • Figure China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Cervical Cancer (2018-2029)

    • Figure China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Colorectal Cancer (2018-2029)

    • Figure China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Prostate Cancer (2018-2029)

    • Figure China Oncology Precision Medicine Production Volume, Production Value and Growth Rate of Kidney Cancer (2018-2029)

    • Figure China Oncology Precision Medicine Sales Volume, Sales Value and Growth Rate of Diagnostic Centers (2018-2029)

    • Figure China Oncology Precision Medicine Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Oncology Precision Medicine Sales Volume, Sales Value and Growth Rate of Research & Academic Institutes (2018-2029)

    • Figure North China Oncology Precision Medicine Market Size and Growth Rate from 2018-2029

    • Figure Central China Oncology Precision Medicine Market Size and Growth Rate from 2018-2029

    • Figure South China Oncology Precision Medicine Market Size and Growth Rate from 2018-2029

    • Figure East China Oncology Precision Medicine Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Oncology Precision Medicine Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Oncology Precision Medicine Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Oncology Precision Medicine Market Size and Growth Rate from 2018-2029

    • Figure Oncology Precision Medicine Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Oncology Precision Medicine Market Share by Type in 2018

    • Figure China Oncology Precision Medicine Market Share by Type in 2023

    • Figure China Oncology Precision Medicine Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Oncology Precision Medicine Production Volume and Growth Rate of Bladder Cancer (2018-2023)

    • Figure China Oncology Precision Medicine Production Volume and Growth Rate of Liver Cancer (2018-2023)

    • Figure China Oncology Precision Medicine Production Volume and Growth Rate of Breast Cancer (2018-2023)

    • Figure China Oncology Precision Medicine Production Volume and Growth Rate of Lung Cancer (2018-2023)

    • Figure China Oncology Precision Medicine Production Volume and Growth Rate of Esophagus Cancer (2018-2023)

    • Figure China Oncology Precision Medicine Production Volume and Growth Rate of Stomach Cancer (2018-2023)

    • Figure China Oncology Precision Medicine Production Volume and Growth Rate of Cervical Cancer (2018-2023)

    • Figure China Oncology Precision Medicine Production Volume and Growth Rate of Colorectal Cancer (2018-2023)

    • Figure China Oncology Precision Medicine Production Volume and Growth Rate of Prostate Cancer (2018-2023)

    • Figure China Oncology Precision Medicine Production Volume and Growth Rate of Kidney Cancer (2018-2023)

    • Figure China Oncology Precision Medicine Market Share by Application in 2018

    • Figure China Oncology Precision Medicine Market Share by Application in 2023

    • Figure China Oncology Precision Medicine Total Market Size and Growth Rate from Consumption End

    • Figure China Oncology Precision Medicine Market Size and Growth Rate of Diagnostic Centers (2018-2023)

    • Figure China Oncology Precision Medicine Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Oncology Precision Medicine Market Size and Growth Rate of Research & Academic Institutes (2018-2023)

    • Table China Oncology Precision Medicine Production Volume by Region (2018-2023)

    • Table China Oncology Precision Medicine Production Volume Share by Region (2018-2023)

    • Figure China Oncology Precision Medicine Production Volume Share by Region (2018-2023)

    • Table China Oncology Precision Medicine Production Value by Region (2018-2023)

    • Table China Oncology Precision Medicine Production Value Share by Region (2018-2023)

    • Figure China Oncology Precision Medicine Production Value Share by Region (2018-2023)

    • Table China Oncology Precision Medicine Sales Volume by Region (2018-2023)

    • Table China Oncology Precision Medicine Sales Volume Share by Region (2018-2023)

    • Figure China Oncology Precision Medicine Sales Volume Share by Region (2018-2023)

    • Table China Oncology Precision Medicine Sales Value by Region (2018-2023)

    • Table China Oncology Precision Medicine Sales Value Share by Region (2018-2023)

    • Figure China Oncology Precision Medicine Sales Value Share by Region (2018-2023)

    • Table North China Oncology Precision Medicine Production Volume by Type (2018-2023)

    • Table North China Oncology Precision Medicine Production Volume Share by Type (2018-2023)

    • Figure North China Oncology Precision Medicine Production Volume Share by Type (2018-2023)

    • Table North China Oncology Precision Medicine Sales Volume by Application (2018-2023)

    • Table North China Oncology Precision Medicine Sales Volume Share by Application (2018-2023)

    • Figure North China Oncology Precision Medicine Sales Volume Share by Application (2018-2023)

    • Table Central China Oncology Precision Medicine Production Volume by Type (2018-2023)

    • Table Central China Oncology Precision Medicine Production Volume Share by Type (2018-2023)

    • Figure Central China Oncology Precision Medicine Production Volume Share by Type (2018-2023)

    • Table Central China Oncology Precision Medicine Sales Volume by Application (2018-2023)

    • Table Central China Oncology Precision Medicine Sales Volume Share by Application (2018-2023)

    • Figure Central China Oncology Precision Medicine Sales Volume Share by Application (2018-2023)

    • Table South China Oncology Precision Medicine Production Volume by Type (2018-2023)

    • Table South China Oncology Precision Medicine Production Volume Share by Type (2018-2023)

    • Figure South China Oncology Precision Medicine Production Volume Share by Type (2018-2023)

    • Table South China Oncology Precision Medicine Sales Volume by Application (2018-2023)

    • Table South China Oncology Precision Medicine Sales Volume Share by Application (2018-2023)

    • Figure South China Oncology Precision Medicine Sales Volume Share by Application (2018-2023)

    • Table East China Oncology Precision Medicine Production Volume by Type (2018-2023)

    • Table East China Oncology Precision Medicine Production Volume Share by Type (2018-2023)

    • Figure East China Oncology Precision Medicine Production Volume Share by Type (2018-2023)

    • Table East China Oncology Precision Medicine Sales Volume by Application (2018-2023)

    • Table East China Oncology Precision Medicine Sales Volume Share by Application (2018-2023)

    • Figure East China Oncology Precision Medicine Sales Volume Share by Application (2018-2023)

    • Table Northeast China Oncology Precision Medicine Production Volume by Type (2018-2023)

    • Table Northeast China Oncology Precision Medicine Production Volume Share by Type (2018-2023)

    • Figure Northeast China Oncology Precision Medicine Production Volume Share by Type (2018-2023)

    • Table Northeast China Oncology Precision Medicine Sales Volume by Application (2018-2023)

    • Table Northeast China Oncology Precision Medicine Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Oncology Precision Medicine Sales Volume Share by Application (2018-2023)

    • Table Southwest China Oncology Precision Medicine Production Volume by Type (2018-2023)

    • Table Southwest China Oncology Precision Medicine Production Volume Share by Type (2018-2023)

    • Figure Southwest China Oncology Precision Medicine Production Volume Share by Type (2018-2023)

    • Table Southwest China Oncology Precision Medicine Sales Volume by Application (2018-2023)

    • Table Southwest China Oncology Precision Medicine Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Oncology Precision Medicine Sales Volume Share by Application (2018-2023)

    • Table Northwest China Oncology Precision Medicine Production Volume by Type (2018-2023)

    • Table Northwest China Oncology Precision Medicine Production Volume Share by Type (2018-2023)

    • Figure Northwest China Oncology Precision Medicine Production Volume Share by Type (2018-2023)

    • Table Northwest China Oncology Precision Medicine Sales Volume by Application (2018-2023)

    • Table Northwest China Oncology Precision Medicine Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Oncology Precision Medicine Sales Volume Share by Application (2018-2023)

    • Table bioMerieux SA Company Profile

    • Table bioMerieux SA Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table Myriad Genetics, Inc Company Profile

    • Table Myriad Genetics, Inc Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table Quest Diagnostics Company Profile

    • Table Quest Diagnostics Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table Illumina, Inc Company Profile

    • Table Illumina, Inc Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table Laboratory Corporation of America Holdings Company Profile

    • Table Laboratory Corporation of America Holdings Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table Almac Group Ltd Company Profile

    • Table Almac Group Ltd Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table MDx Health, Inc Company Profile

    • Table MDx Health, Inc Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table QIAGEN Company Profile

    • Table QIAGEN Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table ANGLE plc Company Profile

    • Table ANGLE plc Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline plc Company Profile

    • Table GlaxoSmithKline plc Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table Pacific Biosciences of California, Inc Company Profile

    • Table Pacific Biosciences of California, Inc Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table Bio-Rad Laboratories, Inc Company Profile

    • Table Bio-Rad Laboratories, Inc Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table Asuragen, Inc Company Profile

    • Table Asuragen, Inc Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table BGI Group Company Profile

    • Table BGI Group Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories Company Profile

    • Table Abbott Laboratories Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche AG Company Profile

    • Table F Hoffmann-La Roche AG Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca PLC Company Profile

    • Table AstraZeneca PLC Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table Konica Minolta, Inc Company Profile

    • Table Konica Minolta, Inc Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table Bristol Myers Squibb Company Profile

    • Table Bristol Myers Squibb Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table Agilent Technologies, Inc Company Profile

    • Table Agilent Technologies, Inc Oncology Precision Medicine Revenue, Price and Gross (2018-2023)

    • Table Opko Health,Inc Company Profile

    • Table Opko Health,Inc Oncology Precision Medicine Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.